News

Roger Montgomery16h
Telix’s growth momentum continues
In this week’s video insight, I discuss the growth of Telix Pharmaceuticals (ASX:TLX). When the Montgomery Fund, The ...
Roger Montgomery15h
A return to fundamentals
It seems like a distant memory now, but 2025 began with an upbeat outlook, buoyed by deregulation and robust earnings. By ...